Should infliximab be used as an adjuvant to IVIG in the treatment of children with kawasaki disease who are at high risk for resistance to conventional therapy?

Shelby Davies, Gabrielle Gold-Von Simson

Research output: Contribution to journalLetterpeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)1756
Number of pages1
JournalPediatric Cardiology
Issue number7
StatePublished - Oct 2013
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this